Sign up to save your podcasts
Or
Share Pfizer-BioNTech release new efficacy data; Girish Mathrubootham, Manav Garg start ‘Together’; and Beerud Sheth on the rise of Gupshup
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Pfizer-BioNTech release new efficacy data; Girish Mathrubootham, Manav Garg start ‘Together’; and Beerud Sheth on the rise of Gupshup
The Pfizer-BioNTech Covid-19 vaccine’s protection against severe cases of the disease holds steady after six months, according to new data released by the companies. The vaccine’s efficacy against those severe cases stayed high at 97 percent for the entire six-month stretch after people got their shots. And in our tech conversation today, Beerud Sheth talks about building Gupshup into a leader in the conversational AI space
View all episodes
By One Thing Today in Tech
1
11 ratings
The Pfizer-BioNTech Covid-19 vaccine’s protection against severe cases of the disease holds steady after six months, according to new data released by the companies. The vaccine’s efficacy against those severe cases stayed high at 97 percent for the entire six-month stretch after people got their shots. And in our tech conversation today, Beerud Sheth talks about building Gupshup into a leader in the conversational AI space